Developing Biotherapeutics for Neurological Disorders

Introduction
Brain disorders such as; Alzheimer's disease, Parkinson's disease, epilepsy, cerebral vascular disease, including stroke, multiple sclerosis, brain trauma and migraine and their sequelae affect ~1bn people worldwide. The economic burden on health providers and governments is tremendous and worryingly this situation will escalate as the expected human life span increases. Throughout the world there are many transdiciplinary teams developing new innovations. Key research initiatives include: genomics, proteomics, cell imaging technologies, stem cell bioengineering, medicinal chemistry, molecular diagnostics, nanobiotechnology for drug delivery and biotherapeutics. Many significant advances have been made but still there remains a huge unmet clinical need for disease-modifying agents that will ameliorate these distressing disorders.

The RSC Biotechnology Group welcome you to this conference, which will bring together inspiring speakers from Europe who will discuss progress in the understanding of the molecular processes that govern normal brain function and dysfunction and how their findings will translate into new clinical candidates. Furthermore, it will provide unique opportunities for specialists to interact and create new collaborations. An important component of the conference is that it will provide good networking opportunities for students, to meet and question the experts and offers the chance to present a poster.